Biosynthesis and biotechnological production of ginsenosides

Biotechnol Adv. 2015 Nov 1;33(6 Pt 1):717-35. doi: 10.1016/j.biotechadv.2015.03.001. Epub 2015 Mar 6.

Abstract

Medicinal plants are essential for improving human health, and around 75% of the population in developing countries relies mainly on herb-based medicines for health care. As the king of herb plants, ginseng has been used for nearly 5,000 years in the oriental and recently in western medicines. Among the compounds studied in ginseng plants, ginsenosides have been shown to have multiple medical effects such as anti-oxidative, anti-aging, anti-cancer, adaptogenic and other health-improving activities. Ginsenosides belong to a group of triterpene saponins (also called ginseng saponins) that are found almost exclusively in Panax species and accumulated especially in the plant roots. In this review, we update the conserved and diversified pathway/enzyme biosynthesizing ginsenosides which have been presented. Particularly, we highlight recent milestone works on functional characterization of key genes dedicated to the production of ginsenosides, and their application in engineering plants and yeast cells for large-scale production of ginsenosides.

Keywords: Accumultation; Biosynthesis; Ginseng; Ginsenoside; Industrial production; Panax; Physiological role; Recombinant yeast cells; Transgenic plants.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biotechnology / methods*
  • Ginsenosides* / biosynthesis
  • Ginsenosides* / chemistry
  • Ginsenosides* / metabolism
  • Metabolic Engineering / methods*
  • Metabolic Networks and Pathways
  • Panax / chemistry
  • Panax / metabolism
  • Plants, Genetically Modified / chemistry
  • Plants, Genetically Modified / metabolism

Substances

  • Ginsenosides